|
|
UNC-Chapel Hill, in conjunction with UNC Health, created Carolina Research Ventures (CRV) to unlock the potential of its technologies and entrepreneurs, advancing their commercialization efforts by providing capital and expertise. Carolina Research Ventures only invests in companies developing or commercializing technology and inventions created at the University or through significant use of University resources. Second, we focus on companies in the life sciences (biopharma, medical devices, diagnostics healthcare IT, and tech-enabled services) and information technologies (software, hardware, apps, data systems, AI/ML systems, tech-enabled services). CRV has partnered with Hatteras Venture Partners (see profile) on two additional investment vehicles, L2 Ventures Fund I and II.
|
